Harper v. Aetna Life Insurance Company

CourtDistrict Court, N.D. Oklahoma
DecidedApril 1, 2020
Docket4:18-cv-00668
StatusUnknown

This text of Harper v. Aetna Life Insurance Company (Harper v. Aetna Life Insurance Company) is published on Counsel Stack Legal Research, covering District Court, N.D. Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Harper v. Aetna Life Insurance Company, (N.D. Okla. 2020).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OKLAHOMA JORDAN HARPER, ) ) Plaintiff, ) ) v. ) Case No. 18-CV-0668-CVE-JFJ ) [BASE FILE] AETNA LIFE INSURANCE COMPANY, ) (Consolidated with 18-CV-0669) a foreign corporation; ) INTEGRATED SERVICE COMPANY, ) an Oklahoma corporation; ) THE INSERV BENEFIT PLAN, and ) DONNA MATLOCK, an individual, ) ) Defendants. ) OPINION AND ORDER Before the Court is plaintiff’s challenge to a denial of benefits under an employee benefit plan (the Plan). Plaintiff filed this action seeking to recover benefits and enforce her rights under the Employee Retirement Income Security Act of 1974, 29 U.S.C. § 1101 et seq. (ERISA). Plaintiff’s husband died in a car accident while allegedly under the influence of amphetamine and methamphetamine. After her claims were denied, plaintiff filed two separate cases in this Court.1 Plaintiff named four defendants in her second-filed complaint. She claims that Aetna Life Insurance Company (Aetna) wrongfully denied benefits, and as de facto or functional fiduciaries, Donna Matlock (Matlock) and Integrated Service Company (Inserv)—because Matlock is the human resources manager for Inserv—breached their fiduciary duties by wrongfully managing the Plan. 1 On December 26, 2018, plaintiff filed her first complaint, which was docketed as 18-CV- 668-CVE. Later that same day, plaintiff filed a second complaint naming Donna Matlock and the other three defendants in case number 18-CV-669-CVE. Matlock is a defendant in case number 18-CV-669-CVE only. The other three defendants are defendants in both 18- CV-668-CVE-FHM and 18-CV-669-CVE. The cases were consolidated on March 5, 2019. See Dkt. # 27. Plaintiff’s only claim is denial of benefits; she does not state a separate claim for breach of fiduciary duty. See 18-CV-669-CVE-JFJ, Dkt. # 2; 18-CV-668-CVE-JFJ, Dkt. # 2. Plaintiff has filed an opening brief (Dkt. #71), defendants have filed responses (Dkt. ## 72, 75), and plaintiff has filed a reply (Dkt. # 76).

Two issues are before the Court in its de novo review of the record: whether there is substantial evidence that decedent was under the influence of intoxicants at the time of his death; and whether plaintiff otherwise qualifies for benefits as both an employee and a dependent. Plaintiff presents a third purely legal question of Inserv’s and Matlock’s alleged status as de facto or functional fiduciaries. I. Background

On December 31, 2017, Douglas Harper (decedent) died in a single vehicle motor accident on Interstate 44 in Creek County, Oklahoma. Dkt. # 71 at 7. He was twenty-eight years old when he died. Dkt. # 68-3, at 80. No one witnessed the accident, and the collision report shows “no skid marks or yaw marks on the road to indicate evasive movement from [the] vehicle . . . .” Dkt. # 68-2, at 102. Decedent’s death certificate shows the cause of death as “multiple blunt force injuries.” Dkt. # 68-3, at 80. However, both the autopsy report and toxicology report show that decedent was under the influence of drugs at the time of his death. See id., at 65, 73. The autopsy report shows that decedent had “a pipe containing a green leafy substance.” Id. at 66. According to the toxicology

report, decedent tested positive for 0.35 mcg/mL (0.035 mg%) of amphetamine and 2.2 mcg/mL (0.22 mg%) of methamphetamine post mortem. Id. at 73. Decedent had a prescription for Adderall (an amphetamine) for 30 mg tablets twice daily. Id. at 122. The Winek’s Drug & Chemical Blood- 2 Level Data 2001 chart, located in the administrative record and used to determine the severity of decedent’s intoxication, shows that 0.35 mcg/mL (0.035 mg%) of amphetamine is between the therapeutic and toxic range. Id. at 136. The chart shows that 2.2 mcg/mL (0.22 mg%) of methamphetamine is within the toxic range.2 Id. at 144.

Plaintiff and decedent were both employees and named beneficiaries under an employee accidental death and personal loss (ADPL) policy. The policy was issued by Aetna through plaintiff’s and decedent’s employer, Integrated Services Company (Inserv), and plaintiff seeks $200,000: $25,000 for basic life insurance, $50,000 for decedent’s basic ADPL, $100,000 for decedent’s dependent ADPL, and $25,000 for plaintiff’s basic ADPL. Dkt. ## 71, at 15; 76, at 11. Under the policy, Aetna acts as the administrator and payer of the claims. Dkt. # 71, at 17. The Plan provides: “Keep in mind that you cannot receive coverage under this Plan as: [1] both an employee

and a dependent; or [2] [a] dependent of more than one employee.” Dkt. # 68-1, at 52. The Plan further provides: [n]o benefits are payable for a loss caused or contributed to by: . . . # Use of alcohol or intoxicants or drugs while operating any form of a motor vehicle whether or not registered for land, air or water use. A motor vehicle accident will be deemed to be caused by the use of alcohol, intoxicants or drugs if it is determined that at the time of the accident you or your covered dependent were: . . . – Operating the motor vehicle while under the influence of an intoxicant or illegal drug; or – Operating the motor vehicle while under the influence of a prescription drug in excess of the amount prescribed by the physician; . . . . 2 Even using a multiplier of 1.5, which the registered nurse opined was the appropriate number to adjust a post mortem sampling, 2.2 mcg/mL (or 0.22 mg%) of methamphetamine is within the toxic range. Dkt. # 68-3, at 144. 3 Id. at 71. Following decedent’s death, plaintiff submitted a claim for basic life insurance, basic ADPL benefits in her own name, and basic and dependent ADPL benefits in decedent’s name. Dkt. # 71, at 8, 10. On June 7, 2018, Aetna sent a letter to plaintiff denying her claim for basic and dependent

ADPL benefits in decedent’s name, citing the intoxication exclusion. Dkt. # 68-2, at 122-23. Plaintiff submitted another claim for basic life insurance and basic ADPL benefits in her name. On August 14, 2018, Aetna sent plaintiff a letter denying the basic ADPL benefits claim because of the intoxication exclusion and denying both claims because of the employee/dependent exclusion. Dkt. # 68-2, at 3-5. In its review, Aetna was advised that no premium deductions were made for plaintiff in 2017. Dkt. # 68-3, at 99. Plaintiff timely appealed her claims for benefits. During the appeals process, Aetna used its in-house claims analyst and a registered nurse to

review the toxicology report.3 The in-house analyst concluded that decedent’s drug level was within the lethal range, although he used the wrong multiples in the Winek’s chart.4 Id. at 35. The registered nurse opined that decedent’s amphetamine level was noted to be 0.35 mcg/mL. The toxic range is any value greater than 0.05 and < 0.1. The lethal range is noted to be any value > 0.1 mcg/mL. The methamphetamine level was noted to be 2.2 mcg/mL. This is also 3 Plaintiff argues that the registered nurse is an in-house nurse and, thus, was unqualified to make a determination of whether decedent was under the influence of drugs at the time of his death. Dkt. ## 71, at 15; 76, at 8. The Court finds this fact to be immaterial because, as discussed in IV.A. infra, the toxicology report is clear that decedent was under the influence of drugs when the accident occurred. 4 In the Winek’s chart, mg/mL * 100 = mg%. See Dkt. # 68-3, at 135. For some reason, Aetna interpreted mcg/mL as equating to mg%. In other words, all of the calculations by Aetna should have been moved to the left one decimal point. (2.2 mcg/mL = 0.0022 mg/mL. 0.0022 mg/mL * 100 = 0.22 mg%.) 4 within the lethal range. The [t]oxic range is 0.06-0.50; lethal range is any value greater than 1.0. . . . It is my clinical opinion that the decedent was not taking the prescribed Adderall 30 mg tabs by mouth twice daily.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Metropolitan Life Insurance v. Glenn
554 U.S. 105 (Supreme Court, 2008)
Chambers v. Family Health Plan Corp.
100 F.3d 818 (Tenth Circuit, 1996)
Kimber v. Thiokol Corporation
196 F.3d 1092 (Tenth Circuit, 1999)
Caldwell v. Life Insurance Co. of North America
287 F.3d 1276 (Tenth Circuit, 2002)
Allison v. Unum Life Insurance Co. of America
381 F.3d 1015 (Tenth Circuit, 2004)
Navarre v. Luna (In Re Luna)
406 F.3d 1192 (Tenth Circuit, 2005)
Hancock v. Metropolitan Life Insurance
590 F.3d 1141 (Tenth Circuit, 2009)
Teets v. Great-West Life & Annuity Ins. Co.
921 F.3d 1200 (Tenth Circuit, 2019)
Johnson v. Health Care Service Corp.
262 F. Supp. 3d 1260 (W.D. Oklahoma, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Harper v. Aetna Life Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/harper-v-aetna-life-insurance-company-oknd-2020.